These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 17546055)
1. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055 [TBL] [Abstract][Full Text] [Related]
2. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346 [TBL] [Abstract][Full Text] [Related]
3. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831 [TBL] [Abstract][Full Text] [Related]
5. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines. Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481 [TBL] [Abstract][Full Text] [Related]
6. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development. Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305 [TBL] [Abstract][Full Text] [Related]
7. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Yamamichi N; Inada K; Ichinose M; Yamamichi-Nishina M; Mizutani T; Watanabe H; Shiogama K; Fujishiro M; Okazaki T; Yahagi N; Haraguchi T; Fujita S; Tsutsumi Y; Omata M; Iba H Cancer Res; 2007 Nov; 67(22):10727-35. PubMed ID: 18006815 [TBL] [Abstract][Full Text] [Related]
8. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells. Vachtenheim J; Ondrusová L; Borovanský J Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088 [TBL] [Abstract][Full Text] [Related]
9. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296 [TBL] [Abstract][Full Text] [Related]
10. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541 [TBL] [Abstract][Full Text] [Related]
11. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. Rosson GB; Bartlett C; Reed W; Weissman BE J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247 [TBL] [Abstract][Full Text] [Related]
12. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb). Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic alterations of BRG1 leads to cancer development through its nuclear-cytoplasmic shuttling abnormalities. Gunduz E; Gunduz M; Nagatsuka H; Beder L; Demircan K; Tamamura R; Hatipoglu OF; Mahmut N; Katase N; Naomoto Y; Nagai N Med Hypotheses; 2006; 67(6):1313-6. PubMed ID: 16824695 [TBL] [Abstract][Full Text] [Related]
14. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494 [TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations of BRG1 promote oral cancer development. Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241 [TBL] [Abstract][Full Text] [Related]
16. Targeted knockout of BRG1 potentiates lung cancer development. Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D Cancer Res; 2008 May; 68(10):3689-96. PubMed ID: 18483251 [TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030 [TBL] [Abstract][Full Text] [Related]
18. The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Yamamichi N; Yamamichi-Nishina M; Mizutani T; Watanabe H; Minoguchi S; Kobayashi N; Kimura S; Ito T; Yahagi N; Ichinose M; Omata M; Iba H Oncogene; 2005 Aug; 24(35):5471-81. PubMed ID: 16007216 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]